Expert Details
Global Reproductive Health, Contraceptive R&D and Translational Research
ID: 727983
Texas, USA
He was the lead-discoverer of Tamoxifen, widely used for the treatment of breast cancer. He has published extensively (196 papers, chapters and reviews) on reproductive biology and contraception, including Birth Control Technologies: Prospects by the year 2000 (1983). He has served on two Institute of Medicine Committees which produced the reports: Contraceptive Research and Development: Looking to the Future (1996) and New Frontiers in Contraceptive Research: A Blueprint for Action (2004).
He has acted as a tecnical consultant for Schering Plough (2009), Schering AG,(joint reseacrh program (2004-2008), Wyeth-Ayerst (1994), GD Searle and Co. (1987-1992) and AstraZeneca (1981-1991) concerning contraceptive R&D.
Education
| Year | Degree | Subject | Institution |
|---|---|---|---|
| Year: 1984 | Degree: MBA | Subject: Management | Institution: University of Texas at San Antonio |
| Year: 1979 | Degree: ScD | Subject: Contributions to Advancement of Science | Institution: University of Cambridge, UK |
| Year: 1962 | Degree: PhD | Subject: Reproductive Physiology | Institution: University of Cambridge, UK |
| Year: 1958 | Degree: Post Graduate Diploma (equivalent to MS) | Subject: Animal Science | Institution: University of Reading, UK |
| Year: 1957 | Degree: BA | Subject: Agriculture | Institution: University of Cambridge, UK |
Work History
| Years | Employer | Title | Department |
|---|---|---|---|
| Years: 1995 to 2010 | Employer: Eastern Virginia Medical School | Title: Professor Emeritus | Department: OB-GYN |
Responsibilities:He has been Director of the Consortium for Industrial Collaboration in Contraceptive Research, a program of CONRAD. |
|||
| Years | Employer | Title | Department |
| Years: 1993 to 1995 | Employer: Baylor College of Medicine | Title: Professor | Department: OB-GYN and Cell Biology |
Responsibilities:He was Director of Reproductive Research in the Reproductive Endocrinology and Infertility Division |
|||
| Years | Employer | Title | Department |
| Years: 1975 to 1993 | Employer: Univerity of Texas Health Science Center at San Antonio | Title: Associate to Full Professor | Department: OB-GYN and Physiology |
Responsibilities:He was Chief, Reproductive Research Division |
|||
| Years | Employer | Title | Department |
| Years: 1972 to 1975 | Employer: World Health Organization | Title: Scientist | Department: Human Reproduction Programme |
Responsibilities:He was a manager of three Task Forces working different approaches to novel contraceptives. |
|||
| Years | Employer | Title | Department |
| Years: 1964 to 1972 | Employer: Worcester Foundation For Experimental Biology, Shrewsbury MA | Title: Postdoc to Senior Scientist | Department: |
Responsibilities:He was a postdoc fellow with MC Chang and then obtained his own NIH funding, including a Research Career Develoment Award. |
|||
| Years | Employer | Title | Department |
| Years: 1961 to 1965 | Employer: ICI Pharmaceuticals (now AstraZeneca) | Title: Technical Officer | Department: Biology |
Responsibilities:He was charged with discovery of new contraceptives. His work resulted in discovery of Tamoxifen, a potent antiestrogen useful for breast cancer therapy. |
|||
Government Experience
| Years | Agency | Role | Description |
|---|---|---|---|
| Years: 1988 to Present | Agency: USAID | Role: Member of Review Team | Description: He was a member of review team evaluating an USIAD program |
| Years: 1993 to Present | Agency: USA | Role: Member of review Team | Description: He was a member of review team evaluating an USIAD program |
| Years: 1992 to Present | Agency: NIH | Role: Member of review panel | Description: Reviewer Ad Hoc Study Section to review Perinatal Emphasis Research Center applications |
| Years: 1991 to Present | Agency: NIH | Role: Chairman of Panel | Description: Chair NIH Special Study Section to review applications for Cooperative Program of Contraceptive Research and Development Centers |
International Experience
| Years | Country / Region | Summary |
|---|---|---|
| Years: 1972 to 1975 | Country / Region: Switzerland | Summary: He worked as a Slentist at WHO, Geneva in the HR program to develop novel contraceptives |
| Years: 1961 to 1966 | Country / Region: UK | Summary: He was employed as a technical Oficer to discover novel contraceptive agents |
Career Accomplishments
| Associations / Societies |
|---|
| He recived a Research Career Development Award from NICHD. |
| Licenses / Certifications |
|---|
| Fellow of Society of Biology, UK Texas Real Estate Broker's License |
| Professional Appointments |
|---|
| Associate Editor for Contraception, Reviewer for many Journals (Endocrinology, Theriogenology, Endocrine, Fertility and Sterility). Reviewer for NIH - Loan Repayment Program, Innovative Research Applications and Ad Hoc Panels. |
| Publications and Patents Summary |
|---|
| He has 148 publications in peer-reviewed Journals and 48 Chapters and reviews. he has 4 patents and one book on Birth Control Technologies.. |
Additional Experience
| Expert Witness Experience |
|---|
| He has been deposed and given testimony 4 times in relation to lawsuits seeking to invalidating the Tamoxifen patent. |
| Training / Seminars |
|---|
| He has given innumerable invited and research lectures and also lectures to medical and dental students. |
| Other Relevant Experience |
|---|
| He has served as a consultant for a variety of government agencies (NIH, NSF, USAID, Fogarty Center), foundations (Andrew W. Mellon) and industry. |
Language Skills
| Language | Proficiency |
|---|---|
| French |